XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Percentage of Net Revenue and Total Accounts Receivable (Detail) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2016 | Jun. 30, 2015 | Mar. 31, 2016
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |
Concentration Risk, Percentage | 10.00% |  |  |  |
Sales Revenue, Net | Governmental - Medicare/Medi-Cal |  |  |  |  |
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |
Concentration Risk, Percentage | 23.60% |  | 31.10% |  |
Sales Revenue, Net | L.A Care |  |  |  |  |
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |
Concentration Risk, Percentage | 14.50% |  | 13.90% |  |
Sales Revenue, Net | Allied Physicians [Member] |  |  |  |  |
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |
Concentration Risk, Percentage | 14.10% |  | 0.00% | [1] |
Sales Revenue, Net | Health Net |  |  |  |  |
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |
Concentration Risk, Percentage | 0.00% | [1] | 12.40% |  |
Accounts Receivable | Governmental - Medicare/Medi-Cal |  |  |  |  |
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |
Concentration Risk, Percentage | 33.40% |  |  |  | 39.30%
Accounts Receivable | Allied Physicians [Member] |  |  |  |  |
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |
Concentration Risk, Percentage | 21.30% |  |  |  | 15.80%
[1] | Represents less than 10%

X
- References No definition available. + Details
Name: | ameh_AccountsReceivableAndNetRevenueLineItems
Namespace Prefix: | ameh_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6351-108592 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13531-108611 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6404-108592 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13537-108611 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MajorCustomersAxis=ameh_MedicareAndMedicalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MajorCustomersAxis=ameh_LCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MajorCustomersAxis=ameh_AlliedPhysiciansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MajorCustomersAxis=ameh_HealthnetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |